| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | VLDLR PCDHGA5 BCAN DLK1 CPS1 VWCE SVEP1 RYR2 STAB1 SNED1 THBS2 FAT2 SCUBE2 SCUBE3 LTBP1 EML1 LTBP4 PCDH7 FBN3 | 4.19e-05 | 749 | 178 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | glutamine-fructose-6-phosphate transaminase (isomerizing) activity | 7.90e-05 | 2 | 178 | 2 | GO:0004360 | |
| GeneOntologyMolecularFunction | dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity | 7.90e-05 | 2 | 178 | 2 | GO:0106073 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity | 1.09e-04 | 11 | 178 | 3 | GO:0052629 | |
| GeneOntologyMolecularFunction | GTPase activator activity | ARHGAP32 AGAP5 RAP1GAP2 AGAP11 ARHGAP12 AGAP9 AGAP7P AGAP4 ARHGAP33 AGAP1 | 2.10e-04 | 279 | 178 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | L-glutamine aminotransferase activity | 2.36e-04 | 3 | 178 | 2 | GO:0070548 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate phosphatase activity | 2.36e-04 | 14 | 178 | 3 | GO:0004438 | |
| GeneOntologyMolecularFunction | phosphatidylinositol monophosphate phosphatase activity | 2.93e-04 | 15 | 178 | 3 | GO:0052744 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 3.58e-04 | 16 | 178 | 3 | GO:0106018 | |
| GeneOntologyMolecularFunction | glucokinase activity | 7.76e-04 | 5 | 178 | 2 | GO:0004340 | |
| GeneOntologyMolecularFunction | hexokinase activity | 7.76e-04 | 5 | 178 | 2 | GO:0004396 | |
| GeneOntologyMolecularFunction | fructokinase activity | 7.76e-04 | 5 | 178 | 2 | GO:0008865 | |
| GeneOntologyBiologicalProcess | fructose 6-phosphate metabolic process | 9.20e-06 | 16 | 179 | 4 | GO:0006002 | |
| GeneOntologyCellularComponent | microfibril | 3.50e-06 | 13 | 179 | 4 | GO:0001527 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS19 BCAN ADAM11 SSPOP SVEP1 ADAMTS10 SNED1 SSC5D THBS2 FCGBP LPA LTBP1 KAZALD1 USH2A LTBP4 FBN3 | 1.72e-04 | 656 | 179 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS19 BCAN ADAM11 SSPOP SVEP1 ADAMTS10 SNED1 SSC5D THBS2 FCGBP LPA LTBP1 KAZALD1 USH2A LTBP4 FBN3 | 1.78e-04 | 658 | 179 | 16 | GO:0030312 |
| MousePheno | fused cornea and lens | 1.78e-07 | 24 | 153 | 6 | MP:0001307 | |
| MousePheno | abnormal pinna reflex | 1.58e-06 | 101 | 153 | 9 | MP:0001485 | |
| MousePheno | absent pinna reflex | 5.72e-06 | 89 | 153 | 8 | MP:0006358 | |
| MousePheno | increased circulating potassium level | 5.43e-05 | 121 | 153 | 8 | MP:0005627 | |
| Domain | EGF_1 | VLDLR BCAN DLK1 ADAM11 VWCE SSPOP SVEP1 STAB1 MEP1A SNED1 THBS2 FAT2 SCUBE2 SCUBE3 LTBP1 USH2A LTBP4 FBN3 | 4.40e-11 | 255 | 178 | 18 | PS00022 |
| Domain | EGF | VLDLR BCAN DLK1 ADAM11 VWCE SVEP1 STAB1 MEP1A SNED1 THBS2 FAT2 FCGBP SCUBE2 SCUBE3 LTBP1 LTBP4 FBN3 | 1.07e-10 | 235 | 178 | 17 | SM00181 |
| Domain | EGF_3 | VLDLR BCAN DLK1 ADAM11 VWCE SSPOP SVEP1 STAB1 MEP1A SNED1 THBS2 FAT2 SCUBE2 SCUBE3 LTBP1 LTBP4 FBN3 | 1.07e-10 | 235 | 178 | 17 | PS50026 |
| Domain | EGF_CA | VLDLR DLK1 VWCE SVEP1 STAB1 SNED1 THBS2 FAT2 SCUBE2 SCUBE3 LTBP1 LTBP4 FBN3 | 1.53e-10 | 122 | 178 | 13 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | VLDLR DLK1 VWCE SVEP1 STAB1 SNED1 THBS2 FAT2 SCUBE2 SCUBE3 LTBP1 LTBP4 FBN3 | 1.88e-10 | 124 | 178 | 13 | IPR001881 |
| Domain | EGF | VLDLR BCAN DLK1 SVEP1 STAB1 MEP1A SNED1 THBS2 FAT2 SCUBE2 SCUBE3 LTBP1 FBN3 | 2.31e-10 | 126 | 178 | 13 | PF00008 |
| Domain | EGF-like_dom | VLDLR BCAN DLK1 ADAM11 VWCE SVEP1 STAB1 MEP1A SNED1 THBS2 FAT2 FCGBP SCUBE2 SCUBE3 LTBP1 LTBP4 FBN3 | 2.63e-10 | 249 | 178 | 17 | IPR000742 |
| Domain | EGF_2 | VLDLR BCAN DLK1 ADAM11 VWCE SSPOP SVEP1 STAB1 MEP1A SNED1 THBS2 FAT2 SCUBE2 SCUBE3 LTBP1 LTBP4 FBN3 | 6.89e-10 | 265 | 178 | 17 | PS01186 |
| Domain | EGF-like_CS | VLDLR BCAN DLK1 ADAM11 VWCE SVEP1 STAB1 MEP1A SNED1 THBS2 FAT2 SCUBE2 SCUBE3 LTBP1 LTBP4 FBN3 | 4.30e-09 | 261 | 178 | 16 | IPR013032 |
| Domain | Growth_fac_rcpt_ | VLDLR RSPO4 VWCE SVEP1 STAB1 SCUBE2 FURIN SCUBE3 LTBP1 KAZALD1 LTBP4 FBN3 | 3.31e-08 | 156 | 178 | 12 | IPR009030 |
| Domain | ASX_HYDROXYL | 3.96e-08 | 100 | 178 | 10 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.94e-08 | 106 | 178 | 10 | IPR000152 | |
| Domain | EGF_CA | 1.30e-07 | 86 | 178 | 9 | PF07645 | |
| Domain | ArfGap | 2.73e-07 | 29 | 178 | 6 | SM00105 | |
| Domain | ARFGAP | 2.73e-07 | 29 | 178 | 6 | PS50115 | |
| Domain | ArfGap | 2.73e-07 | 29 | 178 | 6 | PF01412 | |
| Domain | ArfGAP | 2.73e-07 | 29 | 178 | 6 | IPR001164 | |
| Domain | EGF_Ca-bd_CS | 3.69e-07 | 97 | 178 | 9 | IPR018097 | |
| Domain | EGF_CA | 4.39e-07 | 99 | 178 | 9 | PS01187 | |
| Domain | ANK_REP_REGION | AGAP5 ANKRD9 MUC16 AGAP11 SOWAHC KANK1 ASB16 ANKDD1A AGAP9 AGAP7P FEM1A AGAP4 AGAP1 | 1.01e-06 | 254 | 178 | 13 | PS50297 |
| Domain | Ephrin_rec_like | 2.50e-06 | 11 | 178 | 4 | PF07699 | |
| Domain | EGF_dom | 3.72e-06 | 12 | 178 | 4 | IPR024731 | |
| Domain | EGF_3 | 3.72e-06 | 12 | 178 | 4 | PF12947 | |
| Domain | ANK_REPEAT | AGAP5 ANKRD9 MUC16 AGAP11 SOWAHC KANK1 ASB16 ANKDD1A AGAP7P FEM1A AGAP4 AGAP1 | 5.83e-06 | 253 | 178 | 12 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | AGAP5 ANKRD9 AGAP11 SOWAHC KANK1 ASB16 ANKDD1A AGAP9 AGAP7P FEM1A AGAP4 AGAP1 | 6.07e-06 | 254 | 178 | 12 | IPR020683 |
| Domain | - | AGAP5 ANKRD9 AGAP11 SOWAHC KANK1 ASB16 ANKDD1A AGAP9 FEM1A AGAP4 AGAP1 | 2.68e-05 | 248 | 178 | 11 | 1.25.40.20 |
| Domain | TB | 2.90e-05 | 7 | 178 | 3 | PF00683 | |
| Domain | ANK | AGAP5 ANKRD9 AGAP11 SOWAHC KANK1 ASB16 ANKDD1A AGAP7P FEM1A AGAP4 AGAP1 | 3.00e-05 | 251 | 178 | 11 | SM00248 |
| Domain | TSP1 | 3.57e-05 | 65 | 178 | 6 | SM00209 | |
| Domain | TSP1_rpt | 3.57e-05 | 65 | 178 | 6 | IPR000884 | |
| Domain | TSP1 | 3.57e-05 | 65 | 178 | 6 | PS50092 | |
| Domain | Ankyrin_rpt | AGAP5 ANKRD9 AGAP11 SOWAHC KANK1 ASB16 ANKDD1A AGAP7P FEM1A AGAP4 AGAP1 | 4.43e-05 | 262 | 178 | 11 | IPR002110 |
| Domain | - | 4.60e-05 | 8 | 178 | 3 | 3.90.290.10 | |
| Domain | VWF_dom | 4.75e-05 | 42 | 178 | 5 | IPR001007 | |
| Domain | TB_dom | 6.85e-05 | 9 | 178 | 3 | IPR017878 | |
| Domain | TB | 6.85e-05 | 9 | 178 | 3 | PS51364 | |
| Domain | Ank | ANKRD9 AGAP11 SOWAHC KANK1 ASB16 ANKDD1A AGAP7P FEM1A AGAP4 AGAP1 | 6.88e-05 | 228 | 178 | 10 | PF00023 |
| Domain | Ephrin_rec_like | 8.63e-05 | 25 | 178 | 4 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 8.63e-05 | 25 | 178 | 4 | IPR011641 | |
| Domain | Alg10 | 9.03e-05 | 2 | 178 | 2 | IPR016900 | |
| Domain | GlmS_trans | 9.03e-05 | 2 | 178 | 2 | IPR005855 | |
| Domain | DIE2_ALG10 | 9.03e-05 | 2 | 178 | 2 | PF04922 | |
| Domain | SIS | 9.03e-05 | 2 | 178 | 2 | PF01380 | |
| Domain | CUB | 1.01e-04 | 49 | 178 | 5 | PF00431 | |
| Domain | cEGF | 1.01e-04 | 26 | 178 | 4 | PF12662 | |
| Domain | cEGF | 1.01e-04 | 26 | 178 | 4 | IPR026823 | |
| Domain | CUB | 1.11e-04 | 50 | 178 | 5 | SM00042 | |
| Domain | - | 1.34e-04 | 52 | 178 | 5 | 2.60.120.290 | |
| Domain | CUB | 1.47e-04 | 53 | 178 | 5 | PS01180 | |
| Domain | CUB_dom | 2.08e-04 | 57 | 178 | 5 | IPR000859 | |
| Domain | Ank_2 | 2.26e-04 | 215 | 178 | 9 | PF12796 | |
| Domain | ConA-like_dom | 2.59e-04 | 219 | 178 | 9 | IPR013320 | |
| Domain | SIS | 2.69e-04 | 3 | 178 | 2 | PS51464 | |
| Domain | SIS | 2.69e-04 | 3 | 178 | 2 | IPR001347 | |
| Domain | Galactose-bd-like | 2.80e-04 | 94 | 178 | 6 | IPR008979 | |
| Domain | TSP_1 | 3.34e-04 | 63 | 178 | 5 | PF00090 | |
| Domain | VWFC_1 | 3.70e-04 | 36 | 178 | 4 | PS01208 | |
| Domain | VWFC_2 | 4.57e-04 | 38 | 178 | 4 | PS50184 | |
| Domain | VWC | 4.57e-04 | 38 | 178 | 4 | SM00214 | |
| Domain | - | 6.61e-04 | 73 | 178 | 5 | 2.60.120.260 | |
| Domain | Tyr_Pase_AS | 6.61e-04 | 73 | 178 | 5 | IPR016130 | |
| Domain | VWC_out | 7.37e-04 | 19 | 178 | 3 | SM00215 | |
| Domain | Hexokinase_2 | 8.86e-04 | 5 | 178 | 2 | PF03727 | |
| Domain | GATASE_TYPE_2 | 8.86e-04 | 5 | 178 | 2 | PS51278 | |
| Domain | Hexokinase_BS | 8.86e-04 | 5 | 178 | 2 | IPR019807 | |
| Domain | Hexokinase_C | 8.86e-04 | 5 | 178 | 2 | IPR022673 | |
| Domain | Hexokinase_N | 8.86e-04 | 5 | 178 | 2 | IPR022672 | |
| Domain | Hexokinase_1 | 8.86e-04 | 5 | 178 | 2 | PF00349 | |
| Domain | CPSASE_1 | 8.86e-04 | 5 | 178 | 2 | PS00866 | |
| Domain | HEXOKINASE_2 | 8.86e-04 | 5 | 178 | 2 | PS51748 | |
| Domain | HEXOKINASE_1 | 8.86e-04 | 5 | 178 | 2 | PS00378 | |
| Domain | GATase_2_dom | 8.86e-04 | 5 | 178 | 2 | IPR017932 | |
| Domain | Hexokinase | 1.32e-03 | 6 | 178 | 2 | IPR001312 | |
| Domain | CPSASE_2 | 1.32e-03 | 6 | 178 | 2 | PS00867 | |
| Domain | APC_su10/DOC_dom | 1.84e-03 | 7 | 178 | 2 | IPR004939 | |
| Domain | DOC | 1.84e-03 | 7 | 178 | 2 | PS51284 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 1.84e-03 | 7 | 178 | 2 | IPR005479 | |
| Domain | BC-like_N | 1.84e-03 | 7 | 178 | 2 | IPR005481 | |
| Domain | ZnF_UBR1 | 1.84e-03 | 7 | 178 | 2 | SM00396 | |
| Domain | ANAPC10 | 1.84e-03 | 7 | 178 | 2 | PF03256 | |
| Domain | CPSase_L_D2 | 1.84e-03 | 7 | 178 | 2 | PF02786 | |
| Domain | ZF_UBR | 1.84e-03 | 7 | 178 | 2 | PS51157 | |
| Domain | zf-UBR | 1.84e-03 | 7 | 178 | 2 | PF02207 | |
| Domain | Biotin_carb_N | 1.84e-03 | 7 | 178 | 2 | PF00289 | |
| Domain | Znf_UBR | 1.84e-03 | 7 | 178 | 2 | IPR003126 | |
| Domain | APC10 | 1.84e-03 | 7 | 178 | 2 | SM01337 | |
| Domain | - | 1.87e-03 | 92 | 178 | 5 | 3.90.190.10 | |
| Domain | HECT | 2.10e-03 | 27 | 178 | 3 | PF00632 | |
| Domain | HECTc | 2.10e-03 | 27 | 178 | 3 | SM00119 | |
| Domain | HECT_dom | 2.10e-03 | 27 | 178 | 3 | IPR000569 | |
| Domain | HECT | 2.10e-03 | 27 | 178 | 3 | PS50237 | |
| Domain | Sushi_SCR_CCP_dom | 2.13e-03 | 57 | 178 | 4 | IPR000436 | |
| Domain | hEGF | 2.34e-03 | 28 | 178 | 3 | PF12661 | |
| Domain | PTPc_motif | 2.41e-03 | 59 | 178 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 2.41e-03 | 59 | 178 | 4 | IPR003595 | |
| Domain | EGF_extracell | 2.57e-03 | 60 | 178 | 4 | IPR013111 | |
| Domain | EGF_2 | 2.57e-03 | 60 | 178 | 4 | PF07974 | |
| Domain | Prot-tyrosine_phosphatase-like | 2.58e-03 | 99 | 178 | 5 | IPR029021 | |
| Domain | Biotin_lipoyl | 3.11e-03 | 9 | 178 | 2 | PF00364 | |
| Domain | BIOTINYL_LIPOYL | 3.87e-03 | 10 | 178 | 2 | PS50968 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | ADAMTS19 AMN MUC16 BCAN THSD7B SSPOP GFPT1 ADAMTS10 THBS2 FDX2 PCCA | 1.59e-05 | 250 | 127 | 11 | M27554 |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.47e-05 | 39 | 127 | 5 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.47e-05 | 39 | 127 | 5 | MM15165 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.29e-05 | 68 | 127 | 6 | M27303 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 4.47e-05 | 143 | 127 | 8 | M27275 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.49e-05 | 44 | 127 | 5 | M26969 | |
| Pathway | WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS | 1.12e-04 | 11 | 127 | 3 | M48094 | |
| Pathway | KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM | 2.36e-04 | 34 | 127 | 4 | M15898 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.30e-04 | 37 | 127 | 4 | M27134 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 3.66e-04 | 38 | 127 | 4 | MM14874 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.05e-04 | 39 | 127 | 4 | MM14601 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.51e-04 | 109 | 127 | 6 | MM15164 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 4.92e-04 | 41 | 127 | 4 | MM15630 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.97e-04 | 111 | 127 | 6 | M27416 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 5.40e-04 | 42 | 127 | 4 | M41821 | |
| Pathway | WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER | 5.40e-04 | 42 | 127 | 4 | M45531 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE | 5.72e-04 | 75 | 127 | 5 | M27032 | |
| Pathway | KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM | 6.45e-04 | 44 | 127 | 4 | M8104 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | 7.25e-04 | 79 | 127 | 5 | M897 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 8.30e-04 | 47 | 127 | 4 | M646 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 1.42e-12 | 9 | 179 | 6 | 12640130 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 3.53e-12 | 10 | 179 | 6 | 20664521 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 7.73e-12 | 11 | 179 | 6 | 15381706 | |
| Pubmed | 2.85e-11 | 13 | 179 | 6 | 27713690 | ||
| Pubmed | 4.96e-11 | 14 | 179 | 6 | 22453919 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCA2 SZT2 ANKRD9 UBR4 RAP1GAP2 ELP6 TXNRD2 TMEM127 BAP1 DACT1 KMT2D MDN1 MTMR14 FURIN TMEM132A MTMR3 LRP3 KAZALD1 HERC2 CHPF FEM1A LTBP4 GCN1 ARHGAP33 | 3.03e-09 | 1105 | 179 | 24 | 35748872 |
| Pubmed | AGAP5 ABCA2 WAPL SZT2 TRIM35 AGAP11 URGCP BAP1 STAB1 UBE2O FBXL7 AGAP9 AGAP7P AGAP4 KCNT1 AGAP1 | 1.79e-08 | 529 | 179 | 16 | 14621295 | |
| Pubmed | VLDLR ABCA2 WAPL TTC28 CNST SYNE1 UBR4 RAP1GAP2 GFPT1 STAB1 UBE2O PTPRK CLK1 SUPT5H TPP1 MTMR3 MAST1 DLAT GFPT2 USP54 HERC2 CHPF GEN1 AGAP1 | 5.34e-08 | 1285 | 179 | 24 | 35914814 | |
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 2.76e-07 | 84 | 179 | 7 | 15203218 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | RNASEH2B ADAMTS19 AGAP5 KCNV2 ANKRD9 RSPO4 AGAP11 MYRFL TMEM127 BAP1 FBXL7 MDN1 GAS2L2 CLK1 SUPT5H LTBP1 AGAP9 AGAP7P AGAP4 ZNF791 AGAP1 ZNF239 | 4.91e-07 | 1242 | 179 | 22 | 30973865 |
| Pubmed | ZNF823 TCAF2 ARHGAP32 TTC28 HECTD3 UBR4 MUC16 URB2 HSPA12B GFPT1 RYR2 KMT2D MDN1 CEP72 GFPT2 | 1.24e-06 | 638 | 179 | 15 | 31182584 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | ARHGAP32 AGAP5 AGAP11 AGAP9 AGAP7P AGAP4 WWC1 ARHGAP33 AGAP1 | 2.14e-06 | 218 | 179 | 9 | 33378226 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | ARHGAP32 AGAP5 LZTS3 SYNE1 AGAP11 AGAP9 AGAP7P AGAP4 PCDH7 AGAP1 | 2.19e-06 | 281 | 179 | 10 | 28706196 |
| Pubmed | ABCC1 ARHGAP32 CENPC MTMR1 SIX4 KMT2D DUSP23 MTMR14 PTPRK SLC4A1AP CEP72 SUPT5H MTMR3 INTS4 UBR3 LTBP1 HERC2 GCN1 PCDH7 | 2.26e-06 | 1049 | 179 | 19 | 27880917 | |
| Pubmed | 2.56e-06 | 75 | 179 | 6 | 20637190 | ||
| Pubmed | 3.79e-06 | 21 | 179 | 4 | 37422473 | ||
| Pubmed | 4.62e-06 | 7 | 179 | 3 | 19998449 | ||
| Pubmed | 5.27e-06 | 130 | 179 | 7 | 12421765 | ||
| Pubmed | RAD51B ABCC1 HK1 HK2 TTC28 RBBP8 UBR4 MDN1 SCUBE2 MTMR14 SUPT5H MCM9 LTBP1 CNP | 5.82e-06 | 634 | 179 | 14 | 34591612 | |
| Pubmed | 1.53e-05 | 102 | 179 | 6 | 11214970 | ||
| Pubmed | DDR1 ARHGAP32 AGAP5 LZTS3 AGAP11 MAST1 HERC2 AGAP9 AGAP7P AGAP4 AGAP1 | 1.57e-05 | 430 | 179 | 11 | 32581705 | |
| Pubmed | 1.71e-05 | 104 | 179 | 6 | 10470851 | ||
| Pubmed | Characterization of the ATPase activity of human ATP-binding cassette transporter-2 (ABCA2). | 2.63e-05 | 2 | 179 | 2 | 15999530 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 24990892 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 21504994 | ||
| Pubmed | Homozygosity mapping of a Weill-Marchesani syndrome locus to chromosome 19p13.3-p13.2. | 2.63e-05 | 2 | 179 | 2 | 11941487 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 9060444 | ||
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 11576544 | ||
| Pubmed | Cardiomyocyte protein O-GlcNAcylation is regulated by GFAT1 not GFAT2. | 2.63e-05 | 2 | 179 | 2 | 34735873 | |
| Pubmed | 2.63e-05 | 2 | 179 | 2 | 24084593 | ||
| Pubmed | Association of CACNA1C and SYNE1 in offspring of patients with psychiatric disorders. | 2.63e-05 | 2 | 179 | 2 | 27620326 | |
| Pubmed | O-GlcNAcylation enhances CPS1 catalytic efficiency for ammonia and promotes ureagenesis. | 2.63e-05 | 2 | 179 | 2 | 36064721 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | ARHGAP32 KREMEN1 SZT2 MUC16 ZCCHC2 SVEP1 STAB1 KMT2D LOXHD1 HERC2 CPLANE1 REV1 | 3.20e-05 | 552 | 179 | 12 | 10737800 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | CACNA1C LZTS3 ZCCHC2 VWCE STAB1 CEP72 LTBP1 EML1 AGAP7P CPLANE1 LTBP4 GOLGA2 | 3.68e-05 | 560 | 179 | 12 | 21653829 |
| Pubmed | TTC28 SYNE1 RAP1GAP2 URB2 KLHL32 KANK1 MTMR3 MAST1 HERC3 SENP7 | 5.38e-05 | 407 | 179 | 10 | 12693553 | |
| Pubmed | HAUS6 HK2 POLD2 TXNRD2 GFPT1 UBE2O MDN1 MTMR14 TPP1 SEMA6A GOLGA2 MTARC1 AGAP1 | 6.12e-05 | 686 | 179 | 13 | 28380382 | |
| Pubmed | LZTS3 CENPC UBR4 MTMR1 URGCP CHTF8 UBE2O KANK1 MDN1 SLC4A1AP ARHGAP12 GFPT2 CHPF | 6.39e-05 | 689 | 179 | 13 | 36543142 | |
| Pubmed | Human chromosome 19 and related regions in mouse: conservative and lineage-specific evolution. | 7.15e-05 | 16 | 179 | 3 | 11441184 | |
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 27529678 | ||
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 26855992 | ||
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 18032585 | ||
| Pubmed | Hexokinase regulates Bax-mediated mitochondrial membrane injury following ischemic stress. | 7.88e-05 | 3 | 179 | 2 | 21430642 | |
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 24303013 | ||
| Pubmed | GFPT2/GFAT2 and AMDHD2 act in tandem to control the hexosamine pathway. | 7.88e-05 | 3 | 179 | 2 | 35229715 | |
| Pubmed | Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. | 7.88e-05 | 3 | 179 | 2 | 12270931 | |
| Pubmed | An NGS-based genotyping in LQTS; minor genes are no longer minor. | 7.88e-05 | 3 | 179 | 2 | 32681117 | |
| Pubmed | Effect of Increased IL-1β on Expression of HK in Alzheimer's Disease. | 7.88e-05 | 3 | 179 | 2 | 33525649 | |
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 19049977 | ||
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 33597309 | ||
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 20347420 | ||
| Pubmed | c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis. | 7.88e-05 | 3 | 179 | 2 | 28054552 | |
| Pubmed | Fubp1 supports the lactate-Akt-mTOR axis through the upregulation of Hk1 and Hk2. | 7.88e-05 | 3 | 179 | 2 | 30871777 | |
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 31991528 | ||
| Pubmed | 7.88e-05 | 3 | 179 | 2 | 9806838 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | DAGLB ABCC1 WAPL HK2 HECTD3 TTI2 UBR4 URB2 TMEM127 GFPT1 URGCP UBE2O PTPRK CHPF GCN1 | 1.17e-04 | 942 | 179 | 15 | 31073040 |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.18e-04 | 211 | 179 | 7 | 24097068 | |
| Pubmed | 1.22e-04 | 19 | 179 | 3 | 18711365 | ||
| Pubmed | A germline-specific class of small RNAs binds mammalian Piwi proteins. | 1.23e-04 | 450 | 179 | 10 | 16751776 | |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 1.36e-04 | 95 | 179 | 5 | 29643511 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | ABCC1 URB2 MDN1 CEP72 MTMR3 HYLS1 INTS4 USP54 HERC2 CHPF GCN1 GOLGA2 MTARC1 | 1.56e-04 | 754 | 179 | 13 | 33060197 |
| Pubmed | KIBRA interacts with discoidin domain receptor 1 to modulate collagen-induced signalling. | 1.57e-04 | 4 | 179 | 2 | 18190796 | |
| Pubmed | Direct neuronal glucose uptake heralds activity-dependent increases in cerebral metabolism. | 1.57e-04 | 4 | 179 | 2 | 25904018 | |
| Pubmed | 1.57e-04 | 4 | 179 | 2 | 15611103 | ||
| Pubmed | 1.57e-04 | 4 | 179 | 2 | 11846405 | ||
| Pubmed | 1.57e-04 | 4 | 179 | 2 | 17010949 | ||
| Pubmed | 1.57e-04 | 4 | 179 | 2 | 24145140 | ||
| Pubmed | Pure distal 9p deletion in a female infant with cerebral palsy. | 1.57e-04 | 4 | 179 | 2 | 22876580 | |
| Pubmed | 1.57e-04 | 4 | 179 | 2 | 18467449 | ||
| Pubmed | The RAD51 paralogs ensure cellular protection against mitotic defects and aneuploidy. | 1.57e-04 | 4 | 179 | 2 | 23108668 | |
| Pubmed | 1.57e-04 | 4 | 179 | 2 | 19383796 | ||
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 1.57e-04 | 4 | 179 | 2 | 11104663 | |
| Pubmed | 1.57e-04 | 4 | 179 | 2 | 32152094 | ||
| Pubmed | 1.57e-04 | 4 | 179 | 2 | 12429738 | ||
| Pubmed | Hexokinase activity is required for recruitment of parkin to depolarized mitochondria. | 1.57e-04 | 4 | 179 | 2 | 23962723 | |
| Pubmed | 1.57e-04 | 4 | 179 | 2 | 21677751 | ||
| Pubmed | 1.57e-04 | 4 | 179 | 2 | 17542649 | ||
| Pubmed | The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines. | 1.57e-04 | 4 | 179 | 2 | 14525949 | |
| Pubmed | High 18F-FDG uptake in PMAH correlated with normal expression of Glut1, HK1, HK2, and HK3. | 1.57e-04 | 4 | 179 | 2 | 25766729 | |
| Pubmed | 1.57e-04 | 4 | 179 | 2 | 20957652 | ||
| Pubmed | 1.57e-04 | 4 | 179 | 2 | 16157329 | ||
| Pubmed | 1.75e-04 | 225 | 179 | 7 | 12168954 | ||
| Pubmed | 1.90e-04 | 102 | 179 | 5 | 21926972 | ||
| Pubmed | 2.17e-04 | 233 | 179 | 7 | 37704626 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 2.45e-04 | 168 | 179 | 6 | 30631154 | |
| Pubmed | 2.61e-04 | 5 | 179 | 2 | 19897194 | ||
| Pubmed | 2.61e-04 | 5 | 179 | 2 | 15121843 | ||
| Pubmed | 2.61e-04 | 5 | 179 | 2 | 22124266 | ||
| Pubmed | 2.61e-04 | 5 | 179 | 2 | 16260650 | ||
| Pubmed | 2.61e-04 | 5 | 179 | 2 | 15574336 | ||
| Pubmed | Genetic and clinical correlates of early-outgrowth colony-forming units. | 2.61e-04 | 5 | 179 | 2 | 21493818 | |
| Pubmed | 2.61e-04 | 5 | 179 | 2 | 23383134 | ||
| Pubmed | Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer. | 2.61e-04 | 5 | 179 | 2 | 20845477 | |
| Pubmed | Human RhoGAP domain-containing proteins: structure, function and evolutionary relationships. | 2.61e-04 | 5 | 179 | 2 | 12297274 | |
| Pubmed | 2.61e-04 | 5 | 179 | 2 | 8640223 | ||
| Pubmed | 2.61e-04 | 5 | 179 | 2 | 31663850 | ||
| Pubmed | 2.61e-04 | 5 | 179 | 2 | 26887390 | ||
| Pubmed | 2.61e-04 | 5 | 179 | 2 | 22586439 | ||
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 2.61e-04 | 170 | 179 | 6 | 23314748 | |
| Pubmed | 2.84e-04 | 25 | 179 | 3 | 38877142 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | ABCC1 HK1 ADAM11 URGCP ADAMTS10 DUSP23 PHPT1 TRMT44 SUPT5H TPP1 SPOCD1 LTBP4 WWC1 SENP7 | 3.31e-04 | 925 | 179 | 14 | 28986522 |
| GeneFamily | Ankyrin repeat domain containing | AGAP5 ANKRD9 AGAP11 SOWAHC KANK1 ASB16 ANKDD1A AGAP9 AGAP7P FEM1A AGAP4 AGAP1 | 4.17e-08 | 242 | 114 | 12 | 403 |
| GeneFamily | ArfGAPs | 5.31e-08 | 33 | 114 | 6 | 395 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 5.31e-08 | 17 | 114 | 5 | 1291 | |
| GeneFamily | Alpha-1,2-glucosyltransferases | 3.94e-05 | 2 | 114 | 2 | 448 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 1.05e-04 | 15 | 114 | 3 | 903 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 2.35e-04 | 4 | 114 | 2 | 628 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.58e-04 | 57 | 114 | 4 | 1179 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 8.11e-04 | 7 | 114 | 2 | 785 | |
| GeneFamily | Phosphoinositide phosphatases | 1.06e-03 | 32 | 114 | 3 | 1079 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.96e-03 | 206 | 114 | 6 | 682 | |
| GeneFamily | Low density lipoprotein receptors | 2.94e-03 | 13 | 114 | 2 | 634 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 3.86e-03 | 50 | 114 | 3 | 721 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 6.28e-03 | 19 | 114 | 2 | 50 | |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 1.82e-07 | 37 | 179 | 6 | MM1121 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 5.31e-07 | 44 | 179 | 6 | MM485 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.05e-06 | 196 | 179 | 10 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | RSPO4 BCAN VWCE SSPOP SVEP1 SNED1 THBS2 LTBP1 USH2A LTBP4 FBN3 | 3.25e-06 | 275 | 179 | 11 | M5884 |
| Coexpression | GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_UP | 7.01e-06 | 191 | 179 | 9 | M4702 | |
| Coexpression | NABA_MATRISOME | ADAMTS19 MUC16 RSPO4 BCAN ADAM11 VWCE SSPOP SVEP1 MEP1A ADAMTS10 SNED1 THBS2 SCUBE2 LPA SCUBE3 LTBP1 KAZALD1 SEMA6A USH2A LTBP4 FBN3 | 7.63e-06 | 1026 | 179 | 21 | M5889 |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 1.95e-05 | 166 | 179 | 8 | M39026 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.30e-05 | 191 | 179 | 8 | MM17059 | |
| Coexpression | NABA_MATRISOME | ADAMTS19 MUC16 RSPO4 BCAN ADAM11 VWCE SSPOP SVEP1 MEP1A ADAMTS10 SNED1 THBS2 SCUBE2 LPA SCUBE3 LTBP1 KAZALD1 SEMA6A LTBP4 | 6.45e-05 | 1008 | 179 | 19 | MM17056 |
| Coexpression | GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_DN | 7.32e-05 | 200 | 179 | 8 | M9302 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | CACNA1C TTC28 SVEP1 RYR2 SNED1 THBS2 FBXL7 LTBP1 GFPT2 LTBP4 PCDH7 | 5.24e-10 | 199 | 178 | 11 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | CACNA1C TTC28 SVEP1 RYR2 SNED1 THBS2 FBXL7 LTBP1 GFPT2 PCDH7 | 7.41e-09 | 197 | 178 | 10 | f1c8936986123a3151140c374fcd62d6705c530b |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | LZTS3 SSC5D THBS2 TMEM132A LTBP1 GFPT2 TRIM47 CHPF SPOCD1 LTBP4 | 7.77e-09 | 198 | 178 | 10 | 399760b6b6fef8639ded53b14f251b9fce600e81 |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.40e-08 | 178 | 178 | 9 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.13e-08 | 185 | 178 | 9 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.03e-08 | 188 | 178 | 9 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.61e-08 | 195 | 178 | 9 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.00e-07 | 196 | 178 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.05e-07 | 197 | 178 | 9 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-07 | 198 | 178 | 9 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.09e-07 | 198 | 178 | 9 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.31e-07 | 188 | 178 | 8 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.69e-07 | 189 | 178 | 8 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.01e-06 | 190 | 178 | 8 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.01e-06 | 190 | 178 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-06 | 190 | 178 | 8 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-06 | 191 | 178 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-06 | 191 | 178 | 8 | b51e0f5d1b93f526160c904e9091313a5364f3a7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-06 | 191 | 178 | 8 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-06 | 191 | 178 | 8 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-06 | 192 | 178 | 8 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.09e-06 | 192 | 178 | 8 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 1.09e-06 | 192 | 178 | 8 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.13e-06 | 193 | 178 | 8 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.18e-06 | 194 | 178 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 196 | 178 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 1.27e-06 | 196 | 178 | 8 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.32e-06 | 197 | 178 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.32e-06 | 197 | 178 | 8 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-06 | 200 | 178 | 8 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-06 | 200 | 178 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-06 | 200 | 178 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature_2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.79e-06 | 143 | 178 | 7 | abe6ec0f6956b87f394d537926eb2427fcfad93f | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-06 | 160 | 178 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-06 | 160 | 178 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 4.45e-06 | 164 | 178 | 7 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 5.21e-06 | 168 | 178 | 7 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Airway_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.32e-06 | 173 | 178 | 7 | b23b408acc29a667cce104429afef1a6cf2720a5 | |
| ToppCell | (03)_Secretory|World / shred by cell type and Timepoint | 7.07e-06 | 176 | 178 | 7 | cb7b1945788196ca79007f0768b6576ec885a0e5 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.33e-06 | 177 | 178 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-06 | 179 | 178 | 7 | b7281160c84dd053a2981c9c76ea6cc6d2592cd5 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.12e-06 | 183 | 178 | 7 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.45e-06 | 184 | 178 | 7 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.78e-06 | 185 | 178 | 7 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.01e-05 | 186 | 178 | 7 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.05e-05 | 187 | 178 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.05e-05 | 187 | 178 | 7 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 188 | 178 | 7 | ec0e241de2c8310b4417b9d4e2420d7a1662f1c0 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-05 | 188 | 178 | 7 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-05 | 189 | 178 | 7 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-05 | 189 | 178 | 7 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-05 | 189 | 178 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.16e-05 | 190 | 178 | 7 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-05 | 190 | 178 | 7 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.20e-05 | 191 | 178 | 7 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 1.20e-05 | 191 | 178 | 7 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-05 | 191 | 178 | 7 | cadb7a9de16f4bb21606de0e25cddd2d748c7f0b | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-05 | 191 | 178 | 7 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.25e-05 | 192 | 178 | 7 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-05 | 192 | 178 | 7 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.25e-05 | 192 | 178 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-05 | 192 | 178 | 7 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-05 | 192 | 178 | 7 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 1.25e-05 | 192 | 178 | 7 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.29e-05 | 193 | 178 | 7 | 8f4bf9a2fbedae35432dad96730b00c70185874c | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 193 | 178 | 7 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.29e-05 | 193 | 178 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 193 | 178 | 7 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.29e-05 | 193 | 178 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.29e-05 | 193 | 178 | 7 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 194 | 178 | 7 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 194 | 178 | 7 | 70185c0b8e0f4e896645b17a243482ba3cdf4a5d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 194 | 178 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 194 | 178 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.33e-05 | 194 | 178 | 7 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 194 | 178 | 7 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-05 | 195 | 178 | 7 | c5f33b420c9ac14dc67fea632b8c2bc2442cbf3d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-05 | 195 | 178 | 7 | 23ced69fd904f1d4114b1a7f99f4b5f65ea8824b | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.38e-05 | 195 | 178 | 7 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Duct|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-05 | 195 | 178 | 7 | fdbb4abc0c79a6aeace71bfa5a5c5576ca39d758 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-05 | 195 | 178 | 7 | 219c5d0cde7f6082755154f54db221413ec555cb | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.42e-05 | 196 | 178 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-05 | 197 | 178 | 7 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | COPD-Stromal|COPD / Disease state, Lineage and Cell class | 1.47e-05 | 197 | 178 | 7 | d5390d86acaa8c39f1da893e8d2271f9ed2951d7 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 197 | 178 | 7 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | COPD-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 1.52e-05 | 198 | 178 | 7 | 2f13c0b3372af53d1bd85f9546f315c878580a71 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.52e-05 | 198 | 178 | 7 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | 1.52e-05 | 198 | 178 | 7 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 | |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | 1.52e-05 | 198 | 178 | 7 | ece914c32c9b123b779aa9624b92e6230763a20e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.52e-05 | 198 | 178 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.57e-05 | 199 | 178 | 7 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.57e-05 | 199 | 178 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | medial-2-mesenchymal-Myofibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.57e-05 | 199 | 178 | 7 | 95aae608fa35a9c82b12c6f18937ce636750ca44 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 199 | 178 | 7 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.57e-05 | 199 | 178 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | medial-mesenchymal-Myofibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.57e-05 | 199 | 178 | 7 | e25acdb5809aaff631cb06dbe4c7e59549a0bdb9 | |
| ToppCell | medial-mesenchymal-Myofibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.57e-05 | 199 | 178 | 7 | 9ebf4822ff9fa08574edec5dbf4f2a1488f34b1d | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 200 | 178 | 7 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 200 | 178 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 200 | 178 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| Disease | cerebral palsy (implicated_via_orthology) | 8.22e-12 | 10 | 175 | 6 | DOID:1969 (implicated_via_orthology) | |
| Disease | Hodgkins lymphoma | 9.63e-06 | 82 | 175 | 6 | EFO_0000183 | |
| Disease | Long Qt Syndrome 2 | 1.05e-04 | 3 | 175 | 2 | C3150943 | |
| Disease | mean corpuscular hemoglobin concentration | RAD51B RNASEH2B ABCC1 HK1 TTC28 PCDHGA5 ANKRD9 DLK1 URB2 CPS1 MTMR3 MAST1 GMPR KIF3C AGAP7P CCNI SENP7 AGAP1 | 1.08e-04 | 1105 | 175 | 18 | EFO_0004528 |
| Disease | cognitive function measurement | RAD51B CACNA1C TTC28 SZT2 PCDHGA5 THSD7B ZCCHC2 KLHL32 STAB1 ZBTB45 THBS2 KMT2D PKHD1 MAST1 LTBP1 KIF3C USH2A AGBL1 PCDH7 AGAP1 REV1 | 1.26e-04 | 1434 | 175 | 21 | EFO_0008354 |
| Disease | gamma-glutamylcitrulline measurement | 2.08e-04 | 4 | 175 | 2 | EFO_0800690 | |
| Disease | Machado-Joseph disease (implicated_via_orthology) | 2.08e-04 | 4 | 175 | 2 | DOID:1440 (implicated_via_orthology) | |
| Disease | age-related macular degeneration, cataract, glaucoma | 2.08e-04 | 4 | 175 | 2 | EFO_0001365, MONDO_0005041, MONDO_0005129 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 3.33e-04 | 23 | 175 | 3 | C1708353 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 3.79e-04 | 24 | 175 | 3 | DOID:10595 (implicated_via_orthology) | |
| Disease | Ciliopathies | 5.13e-04 | 110 | 175 | 5 | C4277690 | |
| Disease | nonsyndromic deafness (implicated_via_orthology) | 5.16e-04 | 6 | 175 | 2 | DOID:0050563 (implicated_via_orthology) | |
| Disease | Fuchs' endothelial dystrophy (is_implicated_in) | 5.16e-04 | 6 | 175 | 2 | DOID:11555 (is_implicated_in) | |
| Disease | magnesium measurement | 6.47e-04 | 66 | 175 | 4 | EFO_0004845 | |
| Disease | neuroimaging measurement | RAD51B SZT2 BCAN TG DACT1 FBXL7 FURIN ARHGAP12 PKHD1 EML1 TRIM47 PCCA AGBL1 PCDH7 WWC1 AGAP1 | 6.61e-04 | 1069 | 175 | 16 | EFO_0004346 |
| Disease | Malignant neoplasm of breast | RAD51B ADAMTS19 ABCC1 SYNE1 UBR4 SIX4 BAP1 KMT2D NLRP14 MTMR3 FCRL5 USP54 HERC2 SPOCD1 GEN1 DOP1A | 6.95e-04 | 1074 | 175 | 16 | C0006142 |
| Disease | urinary albumin to creatinine ratio | 7.19e-04 | 179 | 175 | 6 | EFO_0007778 | |
| Disease | blood nickel measurement | 7.62e-04 | 120 | 175 | 5 | EFO_0007583 | |
| Disease | alcoholic liver cirrhosis (is_marker_for) | 1.23e-03 | 9 | 175 | 2 | DOID:14018 (is_marker_for) | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 1.23e-03 | 9 | 175 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | vascular endothelial growth factor A, isoform 121 measurement | 1.23e-03 | 9 | 175 | 2 | EFO_0020847 | |
| Disease | platelet crit | RAD51B CACNA1C VLDLR HK1 TTC28 ANKRD9 ZNF407 DLK1 CPS1 MFN1 LPA ANKDD1A SENP7 ZNF239 | 1.69e-03 | 952 | 175 | 14 | EFO_0007985 |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.72e-03 | 144 | 175 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 1.85e-03 | 41 | 175 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | nucleus accumbens volume change measurement | 1.86e-03 | 11 | 175 | 2 | EFO_0021493 | |
| Disease | high grade glioma (is_marker_for) | 1.99e-03 | 42 | 175 | 3 | DOID:3070 (is_marker_for) | |
| Disease | eye color | 2.05e-03 | 90 | 175 | 4 | EFO_0003949 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.12e-03 | 566 | 175 | 10 | EFO_0007660, EFO_0008354 | |
| Disease | vascular endothelial growth factor A measurement | 2.22e-03 | 12 | 175 | 2 | EFO_0010804 | |
| Disease | glaucoma | 2.30e-03 | 154 | 175 | 5 | MONDO_0005041 | |
| Disease | red blood cell density measurement | RAD51B CACNA1C VLDLR HK1 PCDHGA5 DLK1 CPS1 TG ASB16 PKHD1 GMPR SENP7 AGAP1 | 2.37e-03 | 880 | 175 | 13 | EFO_0007978 |
| Disease | Paraganglioma | 2.61e-03 | 13 | 175 | 2 | C0030421 | |
| Disease | glutaroyl carnitine measurement | 2.61e-03 | 13 | 175 | 2 | EFO_0021005 | |
| Disease | hypothyroidism (implicated_via_orthology) | 2.61e-03 | 13 | 175 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | FEV/FEC ratio | RAD51B KREMEN1 HTR4 PCDHGA5 MYRFL ITGAV TG KANK1 FCGBP CEP72 ARHGAP12 ANKDD1A MTMR3 SCUBE3 LTBP1 LTBP4 | 2.73e-03 | 1228 | 175 | 16 | EFO_0004713 |
| Disease | forced expiratory volume | RAD51B HTR4 RBBP8 PCDHGA5 SYNE1 SVEP1 RYR2 SSC5D SCUBE2 CEP72 ARHGAP12 ANKDD1A | 2.74e-03 | 789 | 175 | 12 | EFO_0004314 |
| Disease | cortical surface area measurement | RAD51B ADAMTS19 CPS1 SVEP1 TG DACT1 FBXL7 ARHGAP12 PKHD1 SEMA6A EML1 PCCA AGBL1 PCDH7 FBN3 WWC1 AGAP1 | 2.77e-03 | 1345 | 175 | 17 | EFO_0010736 |
| Disease | alpha fetoprotein measurement | 3.01e-03 | 100 | 175 | 4 | EFO_0010583 | |
| Disease | corpus callosum volume measurement | 3.01e-03 | 100 | 175 | 4 | EFO_0010299 | |
| Disease | blood cobalt measurement | 3.12e-03 | 101 | 175 | 4 | EFO_0007577 | |
| Disease | mean platelet volume | DAGLB RAD51B ARHGAP32 HAUS6 TTC28 PCDHGA5 MTMR1 DLK1 CPS1 SVEP1 MCM9 ANKDD1A INTS4 LTBP1 | 3.16e-03 | 1020 | 175 | 14 | EFO_0004584 |
| Disease | cognitive inhibition measurement | 3.28e-03 | 50 | 175 | 3 | EFO_0007969 | |
| Disease | intraocular pressure measurement | RAD51B KREMEN1 PCDHGA5 TXNRD2 PKHD1 LTBP1 KAZALD1 HERC2 MLPH | 3.49e-03 | 509 | 175 | 9 | EFO_0004695 |
| Disease | generalised epilepsy | 3.66e-03 | 52 | 175 | 3 | EFO_0005917 | |
| Disease | interleukin 12 measurement | 3.86e-03 | 53 | 175 | 3 | EFO_0004753 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 3.97e-03 | 16 | 175 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | Alpha ketoglutarate measurement | 3.97e-03 | 16 | 175 | 2 | EFO_0010457 | |
| Disease | Acute Cerebrovascular Accidents | 4.07e-03 | 54 | 175 | 3 | C0751956 | |
| Disease | glutarylcarnitine (C5-DC) measurement | 4.49e-03 | 17 | 175 | 2 | EFO_0800030 | |
| Disease | Tachycardia | 5.03e-03 | 18 | 175 | 2 | C0039231 | |
| Disease | Tachyarrhythmia | 5.03e-03 | 18 | 175 | 2 | C0080203 | |
| Disease | adverse effect, response to xenobiotic stimulus | 5.23e-03 | 59 | 175 | 3 | EFO_0009658, GO_0009410 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 5.48e-03 | 60 | 175 | 3 | C4722327 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ADLGQHCRDGGADIS | 1126 | Q14146 | |
| HCRDGGADISQGSDR | 1131 | Q14146 | |
| HGSREEVNETCGEGD | 586 | Q96P64 | |
| LAHGSREEVNETCGE | 471 | Q8TF27 | |
| ETCGEGDGCTALHLA | 481 | Q8TF27 | |
| LLAHGSRDEVNETCG | 751 | Q9UPQ3 | |
| NETCGEGDGRTALHL | 761 | Q9UPQ3 | |
| LLAHGSREEVNETCG | 651 | Q5VTM2 | |
| NETCGEGDGCTALHL | 661 | Q5VTM2 | |
| HTPGDQDCDELGRET | 76 | P0CG13 | |
| TRSDHGGCELASVLQ | 616 | Q99708 | |
| DDLGRGSKACDGVVH | 271 | A6NCS6 | |
| LGEGQFGEVHLCEVD | 616 | Q08345 | |
| ARLHGGFDSDCSEDG | 36 | O00178 | |
| LDCRGGHVQLADGSD | 631 | O75078 | |
| EHGADVGLRTSQGET | 231 | Q96NS5 | |
| GSVCGTDLSRQEGHA | 351 | Q14094 | |
| EGNHTDGAEEAAGSC | 306 | Q92560 | |
| AEGGHECVANGISRN | 1221 | Q5JWR5 | |
| NGGIVIGDRSSHEAC | 271 | Q5I7T1 | |
| GVSDVGSHLDCGAGE | 86 | Q9BXJ7 | |
| SDQEGLGCPERTHGS | 346 | Q9P209 | |
| EGLATGFCRDVHGQL | 211 | Q0PNE2 | |
| GLAVGTDGRVCVDTH | 601 | Q75N90 | |
| GGTCVDDEGRASHAS | 141 | P80370 | |
| AESGCTIEDHVIAGN | 61 | Q96DT6 | |
| TCGGLHGLIVADEEE | 141 | Q9H324 | |
| DGVINGNHRCSLSGE | 846 | Q96MI9 | |
| EGHLICQSGDVLSAR | 146 | P49759 | |
| GAQSHGDNSCGIEIV | 161 | Q13613 | |
| DEALHGGVACGSLTE | 91 | O15315 | |
| GSLAREDHCGVCNGN | 771 | Q8TE59 | |
| IESGACGAFVHGLED | 371 | Q96HW7 | |
| VHDGDSGENGEIACS | 371 | Q9Y5G8 | |
| GHITNCFLSVEGTDG | 106 | Q8IWA4 | |
| DDLTEVLCSGAGGVH | 201 | Q70IA6 | |
| HTLFGVRNEECAAGG | 621 | Q6IWH7 | |
| HNGGTCLEEEEGVRC | 656 | Q96GW7 | |
| DGAATGVDAICTHRL | 12606 | Q8WXI7 | |
| DGAATGVDAICTHRL | 12761 | Q8WXI7 | |
| ERKEHASCGQTGVEN | 5026 | Q9NU22 | |
| HCGEQLECRLDTGGD | 101 | Q96I82 | |
| EEGGVARFQCQIHGL | 151 | Q8IVU1 | |
| GELRGSDHTDVCGNV | 101 | O60299 | |
| VHGLEIEGRDCGEAT | 151 | Q5VT66 | |
| TDRSHLEECLGGAQI | 751 | Q8IX03 | |
| ARSRAEDGGHDTCVA | 391 | Q9NVR5 | |
| GCGSIQERAVLHTDS | 561 | Q8NCE2 | |
| SGESLDGHLQAVGSC | 416 | Q15742 | |
| QGHRVVDIACGSGDA | 4141 | O95714 | |
| GQHGRERTQASAEGC | 406 | Q8IYT1 | |
| CGGNHSVFLLEDGEV | 41 | Q15034 | |
| GTCGIQHLERAGENL | 266 | Q5JUK3 | |
| HVTVCTGELEGAGTD | 556 | Q8IVV2 | |
| DHNCEIGLIVGTGSN | 221 | P52789 | |
| CSERGSDGQDHIRVG | 226 | O14782 | |
| LGDEGEQCSAAHVSR | 226 | P49005 | |
| LAQRHGVDLEGACEA | 96 | Q6P4F2 | |
| GGRSCQADITLHVED | 3091 | Q9NYQ8 | |
| EGATVTLHCEVQRGS | 486 | Q96RD9 | |
| RASGLGDHCEDINEC | 1151 | Q14766 | |
| GCEGDHEETSGVGER | 296 | A6NFC9 | |
| LSCDHRVVDGAVGAQ | 616 | P10515 | |
| VGAGDNISIGSDHCS | 1031 | O60245 | |
| NCQEAEEGGIFILHG | 351 | Q4G148 | |
| ESIVCHGRVGINTDA | 416 | Q96LU7 | |
| GCNGHLEDNDGSTAL | 1291 | Q14678 | |
| QDGSDEHGCLAAVPR | 481 | O75074 | |
| GDLRDCHQPGTSGEI | 426 | Q96MU8 | |
| GHDEDNTRISSAGCL | 2436 | Q92616 | |
| HCQAGDTVGEGDLLV | 711 | P05165 | |
| CGGGTVDLTVHQLEQ | 321 | Q96MM6 | |
| GCDLGEHLLNSGFEV | 371 | A7KAX9 | |
| DQHCEVGLIIGTGTN | 221 | P19367 | |
| HRCIQLSGETDTIGE | 831 | Q08379 | |
| EAGLCAGDLITHVNG | 1011 | Q9Y2H9 | |
| EQSCDSAGEGSERIH | 196 | Q8IWW6 | |
| RVFGCDLGEHLSNSG | 311 | O14559 | |
| STGEVACFGEGIHTA | 1331 | P31327 | |
| AFTHICAGQGEGDVR | 26 | Q96M11 | |
| DRLGNHASDICGGSE | 296 | Q9NYF0 | |
| GGDIEGENCGARLAH | 481 | Q13936 | |
| SRETDCGVHINAGPE | 456 | O94808 | |
| HLGESQESNLRGCGD | 2091 | Q9H799 | |
| GGIVGHDEISRCSLS | 601 | Q03188 | |
| LNARGCEGITDHGVE | 381 | Q9UJT9 | |
| IIHLQEEGASGRFGC | 596 | Q8NCG7 | |
| LEDGVQACHATGCGR | 4841 | Q9Y6R7 | |
| AGSTHGDCSVEVRQE | 546 | Q8NHY3 | |
| DNRHGTRCAGEVAAV | 191 | P09958 | |
| DLALSEGDIHTLGCG | 891 | P06756 | |
| EGDIHTLGCGVAQCL | 896 | P06756 | |
| VDRCGASVEAGGSVH | 61 | Q9BSK4 | |
| CVGDETQRHSVCQGD | 421 | Q9NZP8 | |
| SGEGHAGNLARCSEL | 1351 | Q9BZC7 | |
| INGSTHVLRDAVECG | 351 | Q13639 | |
| HGSREEVNETCGEGD | 586 | Q5VUJ5 | |
| VEGGGTSLHVACELA | 156 | Q96BM1 | |
| AEHLARGTDSCQGDS | 1976 | P08519 | |
| GSRAHITLGCAADVE | 326 | P09543 | |
| EDVDECATGGRCQHG | 356 | Q8N2S1 | |
| GHVDGCLTNDGDTFL | 146 | Q17RS7 | |
| NGCRGDSDTLGALHD | 441 | Q7Z4H7 | |
| GSDGTDINAVCRAHE | 736 | O00423 | |
| SDAGRIACPEATHGE | 5111 | Q8NDH2 | |
| SGHTECAGEVFERNG | 246 | P36959 | |
| AEEGEVHVALCRGQG | 116 | Q9BRP7 | |
| DIDECGNELNGGCVH | 86 | Q9NQ36 | |
| ERQAESCGVGQGHAE | 621 | Q9NQ36 | |
| GITHCGDVDECSINR | 351 | Q8IX30 | |
| HCGIELDEDGSLDGN | 2006 | Q92736 | |
| GCQGSADHVVSISGV | 21 | Q9BZW8 | |
| QDGCHPGDSVERSVT | 16 | Q6PJW8 | |
| AEGLEEADTGASGCH | 241 | Q9BV36 | |
| GHGENSDDLNERCPV | 461 | Q13615 | |
| EEGEGRTIIHCLNGG | 1366 | Q15262 | |
| EDGPQAVSSGHRCEN | 431 | A6NNC1 | |
| HECAEGGENLSVGQR | 1421 | P33527 | |
| HGSVCSDGERAEDFV | 436 | O14926 | |
| ELGNETGCAHLTCEG | 1021 | Q9NXL9 | |
| SLTDVCQLRGEAHGA | 1416 | Q5T011 | |
| GGGVCDDCEHNTTGR | 601 | O75445 | |
| DLNSGSRGCDHLEQE | 266 | Q9BQF6 | |
| RTQGVEGDHCVTSDP | 401 | Q9UPQ4 | |
| AGHCDGQQALDARVG | 551 | Q8IYL2 | |
| THCEQVLGEGALDRG | 466 | Q96LD4 | |
| HTGSEGQGDSRARCD | 571 | Q684P5 | |
| GRAGHEEAATCQVLS | 171 | Q2I0M5 | |
| EGDRQELQGCHTVCG | 2756 | A2VEC9 | |
| EEGHGAGQEGRLCSQ | 2586 | Q8NF91 | |
| GGALVEVTEHVGCES | 431 | Q24JP5 | |
| ASAGLRVQIGCHTDD | 566 | A6NFQ2 | |
| SISRETDCGVHINAG | 471 | Q06210 | |
| LLECFTGEGHQRGQT | 351 | Q8TDN2 | |
| QAGEVDHTLLGQCTG | 296 | Q16819 | |
| SEGQEAHREVAGGAA | 26 | Q9UIU6 | |
| EDHGLGTLQCHVEGD | 206 | P08F94 | |
| HGCEEADRGSSLVGA | 181 | Q53LP3 | |
| CSETASGVDVGGQHE | 521 | O00267 | |
| HEEDAGVVCAGQRVA | 111 | A1L4H1 | |
| CECLGGGRISHQSQD | 71 | Q9NRX4 | |
| ELVGNTTTLCGENGH | 2471 | Q4LDE5 | |
| DDAQVRVGGCGHTTS | 256 | Q8TER0 | |
| GVEDSGLVQGIRCSH | 261 | Q499Z3 | |
| ERQPCGDGNTETHRA | 21 | O75908 | |
| EDVSRVLIHAGGCAN | 271 | Q495B1 | |
| NGGIVIGDRSSHEAC | 271 | Q5BKT4 | |
| LLAHGSREEVNETCG | 606 | A6NIR3 | |
| NETCGEGDGCTALHL | 616 | A6NIR3 | |
| RCILDATGVGCTGDH | 281 | Q8IZ52 | |
| DVNLDIGSGHDTCGE | 616 | Q9C0B9 | |
| QDLGCDHILVIDSGG | 741 | Q8TCY9 | |
| GECGEVVLGHSSLNC | 101 | P16415 | |
| HTGERLCEGKEGSQC | 66 | Q3KP31 | |
| ETLNGQRLGGHFCDV | 21 | Q96K62 | |
| FGGHGICDNIARTVT | 771 | Q9UBZ9 | |
| DCGDGVGARQHVFLV | 6 | Q5TBB1 | |
| QVTECGSVAGFLHGE | 181 | Q6NXR4 | |
| DIERGNTDGLGDCHN | 556 | Q9H2E6 | |
| RQGAHSECEEGAGDF | 211 | Q6ZMY3 | |
| ALVASLGCGHGTEDE | 61 | Q3SY52 | |
| GADQEHLVNGRCVLG | 251 | Q8IYM1 | |
| CSEAGGAGHEEGRAS | 101 | Q9C0C9 | |
| TGCFHSGVVRAEGDV | 441 | Q96DN2 | |
| CSGEGDDSLRIGGQV | 1016 | Q7Z5K2 | |
| GRVCTVADLCQDGHG | 2086 | Q9NY15 | |
| TLGDQTGECRAHGNL | 266 | Q96AY4 | |
| RGSGCERNHGQDSLA | 256 | O14863 | |
| GCVGLSEEEAVARHG | 406 | Q9NNW7 | |
| ESDEEASVGGPERCH | 966 | Q6ZT12 | |
| THQECQTALGATGGD | 606 | Q13470 | |
| GILHARAVCGEDDSS | 451 | P10827 | |
| NDAGELRVHCEGEGG | 1221 | Q9C0G0 | |
| TDQRDTDGDGVGDHC | 821 | P35442 | |
| SISHAAGRVEDALCG | 1336 | Q9C0I4 | |
| TGSQDCIVNHRGEVD | 6 | Q16600 | |
| GEGETEGDVHTSNRL | 2956 | Q5T4S7 | |
| HCADSQGRELAETGL | 236 | P01266 | |
| IHGGTCSRQELGVSD | 56 | O75204 | |
| GIATSERGDEHSLGC | 1041 | Q70EL1 | |
| GCHESCLDEEVEGQG | 521 | O14773 | |
| EDGSCIHGSRQCNGI | 286 | P98155 | |
| VDEANARGEAVGVHC | 81 | Q9BVJ7 | |
| GACVRTTGEELCNGH | 101 | Q5T447 | |
| AGGEVEHASGRTCAV | 351 | Q96NJ5 | |
| KDVLGSEREQHLGCG | 1896 | O14686 | |
| THLCLADNVLGDGGV | 846 | Q86W24 | |
| AVLQHRASGPDGECD | 211 | Q9BWU0 |